CenterWatch

Clinical Trial Details

Overview

Research Study Summary

Clinical Trial to evaluate the effectiveness of investigational medication for the treatment of Osteoarthritis and Rheumatoid Arthritis.

Purpose

Phase IV,Double-Blind, Parallel-Group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis Patients with or at High Risk for Cardiovascular Disease comparing Celecoxib with Naproxen and Ibuprofen

Patient Inclusion Criteria

  • Men or Women 18 yrs or older
  • Diagnosis of Osteoarthritis or Rheumatoid Arthritis of at least 6 months
  • Must be eligible for chronic daily therapy with an NSAID to control symptoms
  • Subject with established or at high risk for Cardiovascular Disease

Patient Exclusion Criteria

  • Has acute joint trauma with symptoms
  • Planned surgery or invasive procedure
  • Known hypersensitivity to celecoxib, ibuprofen, naproxen, aspirin, esomeprazole, sulfonamides, proton pump inhibitors, lactose or NSAIDS
  • Malignancy within the last 5 years
  • GI disorders
To Learn more

CW ID: 108337
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Phase
4
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A

Contact

South Florida Medical Research
21150 Biscayne Blvd. #300
Aventura, FL 33180
Phone: 305-931-8080

View Map

Research Center Information: South Florida Medical Research

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.